The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Anika Therapeutics, Inc(NASDAQ:ANIK) 
Anika Therapeutics, Inc., together with its subsidiaries, operates as a joint preservation company that in the United States, Europe, and internationally. The company's joint pain management products include Monovisc and Orthovisc, which are single- and multi-injection, hyaluronic acid (HA)-based vi...
Website: http://www.anikatherapeutics.com
Founded: 1983
Full Time Employees: 154
Sector: Healthcare
Industry: Biotechnology
Anika Therapeutics Days Payable Outstanding ttm (DPO)
Anika Therapeutics Days Receivable Outstanding ttm (DSO)
Anika Therapeutics Days Inventory Outstanding ttm (DIO)
Anika Therapeutics Op Cashflow Per Share ttm
Anika Therapeutics Free Cashflow Per Share ttm
Anika Therapeutics Cash Per Share ttm
Anika Therapeutics P/S ratio ttm
Anika Therapeutics (GAAP) P/E ratio ttm
Anika Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.